[vc_row][vc_column][vc_message]Check back regularly for additional information on Pre-Conference tracks[/vc_message][vc_column_text]
Wednesday May 27, 2020
[/vc_column_text][vc_empty_space height=”15″][vc_column_text][/vc_column_text][vc_empty_space height=”15″]
Confirmed regulators include: FDA, EMA, PEI, PMDA and Swissmedic.
The highly interactive program will feature presentations and case studies on sterility controls, post manufacturing processing, combination products, and considerations following rapid approvals.[/vc_column_text][/vc_column][vc_column width=”1/4″][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Organizing Committee
[/vc_column_text][vc_empty_space height=”10px”][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text]Karen Nichols, Esq.
Co-Chair
Magenta Therapeutics
United States
Yong Fan, MD
A2Z Reg Solutions
United States
Christopher Bravery, PhD
Consulting on Advanced Biologicals
United Kingdom
Scott Burger, MD
Advanced Cell & Gene Therapy
United States[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]Dominic Wall, PhD, FFSc(RCPA)
Co-Chair
Cell Therapies Pty Ltd, Peter MacCallum Cancer Centre
Australia
Srinivasan Kellathur, PhD
Advanced Therapy Products Unit, Health Sciences Authority
Singapore
Janet Macpherson, PhD
GE Life Sciences
Australia[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”10px”][vc_empty_space height=”10px”]
[/vc_column_text][vc_column_text]
Organizing Committee
[/vc_column_text][vc_empty_space height=”10px”][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][vc_column_text]Jacques Galipeau, MD
Co-Chair
University of Wisconsin-Madison
United States[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text]Mauro Krampera, MD
Co-Chair
University of Verona
Italy[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text]Luc Sensebe, MD, PhD
Co-Chair
ISCT MSC Committee
France[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”10px”]
[/vc_column_text][vc_column_text]
Organizing Committee
[/vc_column_text][vc_empty_space height=”10px”][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text]Ruud Hulspas, PhD
Cellular Technologies Bioconsulting, LLC
Netherlands
Mara Neal, SH(ASCP)MT, MS, MBA
Cook Biotech
United States[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]Vicki Antonenas, MSc
Westmead Hospital
Australia
Paul Wallace, PhD
Roswell Park Comprehensive Cancer Center
United States[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”10px”]
More information on featured key opinion leaders is coming soon.[/vc_column_text][/vc_column][vc_column width=”1/4″][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Co-Chairs
[/vc_column_text][vc_empty_space height=”10px”][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text]Bill Milligan
Steminent Biotherapeutics
Canada/Taiwan[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]Patrick Rivers, MBA
Aquilo Capital
United States[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column]
[/vc_column_text][vc_column_text]
Organizing Committee
[/vc_column_text][vc_empty_space height=”10px”][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][vc_column_text]Elizabeth J. Shpall, MD
Co-Chair
MD Anderson Cancer Center
United States[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text]Joanne Kurtzberg, MD
Co-Chair
Carolina’s Cord Blood Bank Duke University Medical Center
United States[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text]Ngaire Elwood, PhD
BMDI Cord Blood Bank and Murdoch Children’s Research Institute
Australia[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space]
Organizing Committee
[/vc_column_text][vc_empty_space height=”10″][vc_column_text]Sandeep Soni, MD
Chair
Stanford University
United States[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column]
ISCT-FACT Quality Boot Camp
Enhance your knowledge by attending ISCT-FACT Quality Boot Camp sessions that will address quality principles core to your cellular therapy program, including assessing the effectiveness of your QM plan, challenges programs face when implementing and incorporating Immune Effector Cells into the QM plan, guidance on navigating process validation, and resolving and reporting occurrences.
In an effort to customize Quality Boot Camp content to attendee needs, register early and participate in a survey on QM topics. During the boot camp, join in roundtable discussions and leverage QA experts for ideas on how to enhance your program’s quality improvement program.
[/vc_column_text][/vc_column][vc_column width=”1/4″][vc_column_text][/vc_column_text][/vc_column][/vc_row]